Abhijit Ghosh and Zubin J Daruwalla

Abhijit is Singapore Healthcare & Pharmaceutical Leader and Tax Partner at PwC Singapore.

Zubin is the Southeast Asia Healthcare Consulting Director at PwC. 

Contact Information:
Website: View
LinkedIn: View
All Posts:
Back to contributors.
Join the community

Most Read

1. Indonesia bets on stem cell rules to boost longevity care 2. IHH Singapore goes preventive with new Healthspan programme 3. Health ministry unveils homegrown AI model built for patients 4. Australia funds $10.4m RNA lung therapy trials at Monash 5. AI in pharma market to hit $28.6b by 2034 on drug discovery push

Resource Center

The Untold Story of the Telehealth Surge: New Partnerships and New Risks

AI Adoption and Maturity in Healthcare: An Industry Benchmark

Print Issue

Read Here
Advertise
Sign Up

Partner Events

Sep
09

Medical Fair Asia, Medical Manufacturing Asia & RehaCare Asia 2026

Event News

Medical Taiwan 2026 closes with $168.7m in business opportunities
Medical Taiwan 2026 closes with $168.7m in business opportunities
Demand was strong for AI-driven and digital healthcare solutions.
Taiwan shifts toward AI-driven, home-based healthcare
Taiwan shifts toward AI-driven, home-based healthcare
Diffusion to confusion: Solving APAC’s healthcare coordination crisis
Diffusion to confusion: Solving APAC’s healthcare coordination crisis
Inside Makati Life Medical Center’s win at the Healthcare Asia Awards 2026
Inside Makati Life Medical Center’s win at the Healthcare Asia Awards 2026

Videos

Home care growth pulls Joson-Care beyond ICU bed market

Home care growth pulls Joson-Care beyond ICU bed market

Hiwin robots extend therapist reach amid rehab staff shortage

Hiwin robots extend therapist reach amid rehab staff shortage

Arbo3 pushes automatic air control as hospital staffing tightens

Arbo3 pushes automatic air control as hospital staffing tightens

Wound care demand climbs as Taiwan's over-65s pass 20%

Wound care demand climbs as Taiwan's over-65s pass 20%

View more videos

Partner Sites

Singapore Business Review
Singapore Business Review
Insurance Asia
Insurance Asia
Asian Business Review
Asian Business Review
Asian Banking and Finance
Asian Banking and Finance
Hong Kong Business
Hong Kong Business
Asian Power
Asian Power
Retail Asia
Retail Asia
Real Estate Asia
Real Estate Asia

Commentary

Healthcare

AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings

Healthcare

Beyond symptom control: Redefining IMID care in Malaysia

Healthcare

How decentralised clinical trials can unlock Asia's research potential